Page last updated: 2024-08-21

pyrazines and Hemophilia B

pyrazines has been researched along with Hemophilia B in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Downey, HD; Dunn, D; Finn, JD; High, KA; Hui, D; Mingozzi, F; Pien, GC; Zhou, S	1
Elia, JR; Hirsch, ML; Kafri, T; Kantor, B; Lothrop, CD; Monahan, PE; Samulski, RJ; Sarkar, R; Sun, J; Tillson, DM	1

Other Studies

2 other study(ies) available for pyrazines and Hemophilia B

Article	Year
Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction. Molecular therapy : the journal of the American Society of Gene Therapy, 2010, Volume: 18, Issue:1 Topics: Animals; Antigen Presentation; Boronic Acids; Bortezomib; Capsid Proteins; CD8-Positive T-Lymphocytes; Cell Line; Dependovirus; Genes, MHC Class I; Genetic Vectors; Hemophilia B; Humans; Mice; Protease Inhibitors; Pyrazines; Transduction, Genetic	2010
Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Molecular therapy : the journal of the American Society of Gene Therapy, 2010, Volume: 18, Issue:11 Topics: Animals; Blood Coagulation; Boronic Acids; Bortezomib; Cell Nucleus; Combined Modality Therapy; Dependovirus; Disease Models, Animal; Dogs; Factor IX; Factor VIII; Female; Genetic Therapy; Genetic Vectors; Genome, Viral; Hemophilia B; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protease Inhibitors; Pyrazines; Transgenes	2010

Article

Year

Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction.

Molecular therapy : the journal of the American Society of Gene Therapy, 2010, Volume: 18, Issue:1

Topics: Animals; Antigen Presentation; Boronic Acids; Bortezomib; Capsid Proteins; CD8-Positive T-Lymphocytes; Cell Line; Dependovirus; Genes, MHC Class I; Genetic Vectors; Hemophilia B; Humans; Mice; Protease Inhibitors; Pyrazines; Transduction, Genetic

2010

Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application.

Molecular therapy : the journal of the American Society of Gene Therapy, 2010, Volume: 18, Issue:11

Topics: Animals; Blood Coagulation; Boronic Acids; Bortezomib; Cell Nucleus; Combined Modality Therapy; Dependovirus; Disease Models, Animal; Dogs; Factor IX; Factor VIII; Female; Genetic Therapy; Genetic Vectors; Genome, Viral; Hemophilia B; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protease Inhibitors; Pyrazines; Transgenes

2010